110 related articles for article (PubMed ID: 9718276)
1. Human 5-HT1F receptor-stimulated [35S]GTPgammaS binding: correlation with inhibition of guinea pig dural plasma protein extravasation.
Wainscott DB; Johnson KW; Phebus LA; Schaus JM; Nelson DL
Eur J Pharmacol; 1998 Jul; 352(1):117-24. PubMed ID: 9718276
[TBL] [Abstract][Full Text] [Related]
2. G-protein activation at 5-HT1A receptors by the 5-ht1F ligand LY334370 in guinea-pig brain sections and recombinant cell lines.
Dupuis DS; Colpaert FC; Pauwels PJ
Br J Pharmacol; 1998 May; 124(2):283-90. PubMed ID: 9641544
[TBL] [Abstract][Full Text] [Related]
3. Autoradiography of serotonin 5-HT1A receptor-activated G proteins in guinea pig brain sections by agonist-stimulated [35S]GTPgammaS binding.
Dupuis DS; Palmier C; Colpaert FC; Pauwels PJ
J Neurochem; 1998 Mar; 70(3):1258-68. PubMed ID: 9489749
[TBL] [Abstract][Full Text] [Related]
4. Magnitude of 5-HT1B and 5-HT1A receptor activation in guinea-pig and rat brain: evidence from sumatriptan dimer-mediated [35S]GTPgammaS binding responses.
Dupuis DS; Perez M; Halazy S; Colpaert FC; Pauwels PJ
Brain Res Mol Brain Res; 1999 Apr; 67(1):107-23. PubMed ID: 10101238
[TBL] [Abstract][Full Text] [Related]
5. How efficacious are 5-HT1B/D receptor ligands: an answer from GTP gamma S binding studies with stably transfected C6-glial cell lines.
Pauwels PJ; Tardif S; Palmier C; Wurch T; Colpaert FC
Neuropharmacology; 1997; 36(4-5):499-512. PubMed ID: 9225275
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of 5-HT1B/1D receptor agonists on neurogenic dural plasma extravasation and vasodilation in anaesthetized rats.
Shepherd SL; Williamson DJ; Beer MS; Hill RG; Hargreaves RJ
Neuropharmacology; 1997; 36(4-5):525-33. PubMed ID: 9225277
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological analysis of G-protein activation mediated by guinea-pig recombinant 5-HT1B receptors in C6-glial cells: similarities with the human 5-HT1B receptor.
Pauwels PJ; Wurch T; Palmier C; Colpaert FC
Br J Pharmacol; 1998 Jan; 123(1):51-62. PubMed ID: 9484854
[TBL] [Abstract][Full Text] [Related]
8. 5-Hydroxytryptamine1A and 5-hydroxytryptamine1B receptors stimulate [35S]guanosine-5'-O-(3-thio)triphosphate binding to rodent brain sections as visualized by in vitro autoradiography.
Waeber C; Moskowitz MA
Mol Pharmacol; 1997 Oct; 52(4):623-31. PubMed ID: 9380025
[TBL] [Abstract][Full Text] [Related]
9. The 5-HT1D receptor antagonist GR-127,935 prevents inhibitory effects of sumatriptan but not CP-122,288 and 5-CT on neurogenic plasma extravasation within guinea pig dura mater.
Yu XJ; Cutrer FM; Moskowitz MA; Waeber C
Neuropharmacology; 1997 Jan; 36(1):83-91. PubMed ID: 9144644
[TBL] [Abstract][Full Text] [Related]
10. 5-HT-stimulated [35S]guanosine-5'-O-(3-thio)triphosphate binding as an assay for functional activation of G proteins coupled with 5-HT1B receptors in rat striatal membranes.
Odagaki Y; Toyoshima R
Naunyn Schmiedebergs Arch Pharmacol; 2006 Feb; 372(5):335-45. PubMed ID: 16491386
[TBL] [Abstract][Full Text] [Related]
11. Lack of evidence of kappa2-selective activation of G-proteins: kappa opioid receptor stimulation of [35S] GTPgammaS binding in guinea pig brain.
Childers SR; Xiao R; Vogt L; Sim LJ
Biochem Pharmacol; 1998 Jul; 56(1):113-20. PubMed ID: 9698095
[TBL] [Abstract][Full Text] [Related]
12. The putative <> 5-HT(1A) receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT(1A) receptors.
Cosi C; Koek W
Eur J Pharmacol; 2000 Jul; 401(1):9-15. PubMed ID: 10915831
[TBL] [Abstract][Full Text] [Related]
13. Serotonin 5-HT(1B/1D) agonist-stimulated [(35)S]GTPgammaS binding in rat and guinea pig striatal membranes.
Mize AL; Alper RH
Brain Res; 1999 Jul; 836(1-2):229-36. PubMed ID: 10415426
[TBL] [Abstract][Full Text] [Related]
14. Characterization of 5-HT1A receptor-mediated [35S]GTPgammaS binding in rat hippocampal membranes.
Alper RH; Nelson DL
Eur J Pharmacol; 1998 Feb; 343(2-3):303-12. PubMed ID: 9570480
[TBL] [Abstract][Full Text] [Related]
15. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterisation of [35S]-GTPgammaS binding to Chinese hamster ovary cell membranes stably expressing cloned human 5-HT1D receptor subtypes.
Thomas DR; Faruq SA; Balcarek JM; Brown AM
J Recept Signal Transduct Res; 1995; 15(1-4):199-211. PubMed ID: 8903941
[TBL] [Abstract][Full Text] [Related]
17. Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).
Martin GR; Robertson AD; MacLennan SJ; Prentice DJ; Barrett VJ; Buckingham J; Honey AC; Giles H; Moncada S
Br J Pharmacol; 1997 May; 121(2):157-64. PubMed ID: 9154322
[TBL] [Abstract][Full Text] [Related]
18. Agonist-stimulated [35S]GTPgammaS autoradiography: optimization for high sensitivity.
Happe HK; Bylund DB; Murrin LC
Eur J Pharmacol; 2001 Jun; 422(1-3):1-13. PubMed ID: 11430907
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of dopamine-stimulated [35S]-guanosine 5'(gamma-thiotriphosphate) ([35S]GTPgammaS) binding in rat striatal membranes.
Rinken A; Finnman UB; Fuxe K
Biochem Pharmacol; 1999 Jan; 57(2):155-62. PubMed ID: 9890563
[TBL] [Abstract][Full Text] [Related]
20. Effects of PNU-109,291, a selective 5-HT1D receptor agonist, on electrically induced dural plasma extravasation and capsaicin-evoked c-fos immunoreactivity within trigeminal nucleus caudalis.
Cutrer FM; Yu XJ; Ayata G; Moskowitz MA; Waeber C
Neuropharmacology; 1999 Jul; 38(7):1043-53. PubMed ID: 10428423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
